diabetes glp-1 agonist GLP1 Receptor Agonists—Effects beyond Obesity and Frontiers | Exploring the multifaceted
Description
These groups do not represent contraindications for GLP-1RA therapy
doi: 10.2337/dbi20-0017 41 VolkeVKatusUJohannsonAToompereKHeinlaKRnkorgKet al
[Article] [PubMed] [PMC]19
Liraglutide attenuates nonalcoholic fatty liver disease by modulating gut microbiota in rats administered a high-fat diet
"The potential increase was smallfewer than one additional case per 2,000 GLP-1RA users, while these medications have very well-established benefits for diabetes, obesity, and heart and kidney health
Table of Contents: Is Zepbound better than semaglutide GLP-1 for weight loss
